Several pharmaceutical companies such as Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK) , and Bayer (NYSE: have been taking steps to infuse their pipelines with new drug drugs by developing incubators to identify life science innovations that fit in with their longterm goals. Now Celgene (NASDAQ: CELG) is collaborating with a biotech incubator backed by early stage life science and healthcare investor Versant Ventures, according to a company statement.
{iframe}http://medcitynews.com/2013/11/vc-backed-biotech-incubator-collaborates-celgene/{/iframe}